天然化合物托利德通过促进小细胞肺癌中ROS积累来诱导-3/GSDME介导的热
Yuheng Yan1, Zhaolin Xu1, Chengyan Wang1
1Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei Province, China.
Cancer cell international
|November 29, 2025
概括
三胺 (TPL) 通过诱导细胞灭绝,即编程细胞死亡,对小细胞肺癌 (SCLC) 产生抗瘤作用. 这种天然化合物为积极的SCLC治疗提供了新的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有有限治疗选择的侵袭性恶性瘤.
- 三酸 (TPL) 是一种天然化合物,已证明具有广泛的抗瘤特性.
- 在SCLC中TPL的治疗潜力以前没有被研究过.
研究的目的:
- 为了研究TPL对SCLC的抗瘤作用.
- 为了阐明SCLC中TPL诱导的细胞死亡的机制.
- 在临床前SCLC模型中评估TPL的治疗疗效.
主要方法:
- 在体外测试 (CCK-8,EDU,细胞周期,Transwell) 评估了TPL对SCLC细胞增殖,迁移和入侵的影响.
- 网络药理学确定了TPL的潜在抗瘤标.
- 热的分析是通过形态学,LDH测定和西部斑点.
- 在活体中,使用老鼠异种移植模型证实了疗效.
主要成果:
- TPL抑制了SCLC细胞增殖,诱导了S相细胞周期停止,并减少了迁移和入侵.
- 网络药理学建议TPL调节炎症和亡途径.
- TPL引发了卡斯帕-3/GSDME介导的热,这取决于反应性氧物种 (ROS) 的积累.
- 在体内,TPL抑制了瘤的生长,并诱导了灭.
结论:
- TPL对SCLC具有显著的抗瘤活性.
- 在SCLC细胞中,TPL通过ROS积累和caspase-3/GSDME激活诱导Pyroptosis.
- TPL代表了SCLC治疗的有前途的治疗剂,提供了新的见解.
相关概念视频
Caspases
13.6K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.6K
The Extrinsic Apoptotic Pathway
8.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K


